Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Inducing mitophagy in diabetic platelets protects against severe oxidative stress.

Lee SH, Du J, Stitham J, Atteya G, Lee S, Xiang Y, Wang D, Jin Y, Leslie KL, Spollett G, Srivastava A, Mannam P, Ostriker A, Martin KA, Tang WH, Hwa J.

EMBO Mol Med. 2016 Jul 1;8(7):779-95. doi: 10.15252/emmm.201506046. Print 2016 Jul.

2.

Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.

Michaud TL, Abraham J, Jalal H, Luepker RV, Duval S, Hirsch AT.

J Am Heart Assoc. 2015 Dec 23;4(12). pii: e002321. doi: 10.1161/JAHA.115.002321.

3.

The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation.

Ye W, Brandle M, Brown MB, Herman WH.

Diabetes Technol Ther. 2015 Oct;17(10):701-11. doi: 10.1089/dia.2014.0304. Epub 2015 Jul 29.

4.

Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking?

Siegel AJ.

Open Heart. 2015 Jul 2;2(1):e000102. doi: 10.1136/openhrt-2014-000102. eCollection 2015. Review.

5.

Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor.

Xiang Y, Cheng J, Wang D, Hu X, Xie Y, Stitham J, Atteya G, Du J, Tang WH, Lee SH, Leslie K, Spollett G, Liu Z, Herzog E, Herzog RI, Lu J, Martin KA, Hwa J.

Blood. 2015 May 28;125(22):3377-87. doi: 10.1182/blood-2015-01-620278. Epub 2015 Mar 26.

6.

Clinician's guide to the updated ABCs of cardiovascular disease prevention.

Kohli P, Whelton SP, Hsu S, Yancy CW, Stone NJ, Chrispin J, Gilotra NA, Houston B, Ashen MD, Martin SS, Joshi PH, McEvoy JW, Gluckman TJ, Michos ED, Blaha MJ, Blumenthal RS.

J Am Heart Assoc. 2014 Sep 22;3(5):e001098. doi: 10.1161/JAHA.114.001098. Review.

7.

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC; HIV Medicine Association of the Infectious Diseases Society of America..

Clin Infect Dis. 2014 Nov 1;59(9):e96-138. doi: 10.1093/cid/ciu617. Epub 2014 Sep 17.

8.

Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Fiscella K, Winters PC, Mendoza M, Noronha GJ, Swanger CM, Bisognano JD, Fortuna RJ.

J Gen Intern Med. 2015 Feb;30(2):155-60. doi: 10.1007/s11606-014-2985-8.

9.

Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking.

Łabuz-Roszak B, Pierzchała K, Tyrpień K.

J Endocrinol Invest. 2014 Apr;37(4):331-8. doi: 10.1007/s40618-013-0012-2. Epub 2014 Jan 9.

10.

Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults.

Kalyani RR, Lazo M, Ouyang P, Turkbey E, Chevalier K, Brancati F, Becker D, Vaidya D.

Diabetes Care. 2014;37(3):830-8. doi: 10.2337/dc13-1755. Epub 2013 Oct 31.

11.

Achievement of cardiometabolic goals among diabetic patients in Spain. A nationwide population-based study.

Navarro-Vidal B, Banegas JR, León-Muñoz LM, Rodríguez-Artalejo F, Graciani A.

PLoS One. 2013 Apr 18;8(4):e61549. doi: 10.1371/journal.pone.0061549. Print 2013.

12.

Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland.

Labuz-Roszak B, Pierzchala K, Skrzypek M, Swiech M, Machowska-Majchrzak A.

BMC Cardiovasc Disord. 2012 Oct 31;12:98. doi: 10.1186/1471-2261-12-98.

13.

Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog.

Young JR, McAdam-Marx C.

Clin Med Insights Endocrinol Diabetes. 2010;3:65-80. doi: 10.4137/CMED.S5330. Epub 2010 Dec 5.

14.

Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brain.

Duelsner A, Gatzke N, Glaser J, Hillmeister P, Li M, Lee EJ, Lehmann K, Urban D, Meyborg H, Stawowy P, Busjahn A, Nagorka S, Persson AB, Buschmann IR.

J Cereb Blood Flow Metab. 2012 Jan;32(1):105-14. doi: 10.1038/jcbfm.2011.113. Epub 2011 Aug 10.

15.

Placebo - More hatred than love.

Zhang HL.

J Neurosci Rural Pract. 2011 Jan;2(1):105-7. doi: 10.4103/0976-3147.80089.

16.

Antiplatelet combinations for prevention of atherothrombotic events.

Bollati M, Gaita F, Anselmino M.

Vasc Health Risk Manag. 2011 Jan 12;7:23-30. doi: 10.2147/VHRM.S12271. Review.

17.

Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.

Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, Lavikainen P, Jula A, Junnila SY, Kettunen R, Huupponen R.

Br J Clin Pharmacol. 2011 May;71(5):766-76. doi: 10.1111/j.1365-2125.2010.03895.x.

Supplemental Content

Support Center